IGF::OT::IGF
$693,056,927
| Recipient | REGENERON PHARMACEUTICALS INC UEI N3F9MH7E6HD6 |
|---|---|
| Award ID | HHSO100201700016C |
| Award amount | $693,056,927 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| PSC | AN13 |
| Start date | Sep 30, 2017 |
| End date | Sep 29, 2027 |
| Place of performance | TARRYTOWN, NY |
| Record updated | Dec 5, 2022 |
View the official award record
More awards won by REGENERON PHARMACEUTICALS INC
PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.
Department of Defense · $5,565,000,000 · Jan 12, 2021
IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
Department of Health and Human Services · $284,843,230 · Sep 21, 2017
IGF::OT::IGF
Department of Health and Human Services · $8,601,629 · Aug 9, 2016
EVKEEZA DRUG
Department of Veterans Affairs · $494,095 · Nov 24, 2021
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids